0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

An Agent Effective Against Cryptococcosis of the Central Nervous System

ARTHUR BIDDLE, M.D.; HAROLD KOENIG, M.D.
AMA Arch Intern Med. 1958;102(5):801-805. doi:10.1001/archinte.1958.00260220117012.
Text Size: A A A
Published online

Introduction  In 1950, Mosberg and Arnold reviewed all reported cases of cryptococcosis.1 In summarizing results with more than 25 therapeutic agents, they concluded that "no methods of treatment have proved effective... any encouragement provided by an apparent response to a drug is in most cases nullified by an equally discouraging response when the same drug is employed on another patient."In 1952, Carton2 summarized the approximately 200 reported cases of cryptococcosis with central nervous system involvement with the statement that of the 14 patients alive at the time of their respective reports only 1 could be considered cured. (This patient was well and apparently free of infection six years after treatment with sulfadiazine.3) Carton then summarized the previously reported experiences with cycloheximide (Actidione, Upjohn), including seven fairly well documented cases, by saying "the use of Actidione in the central nervous system disease has been unsatisfactory, except for

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();